AbbVie Inc (NYSE: ABBV) announced on Friday the declaration by its board of directors of a quarterly cash dividend of USD1.07 per share.
This cash dividend is payable on 15 November 2019 to stockholders of record at the close of business on 15 October 2019.
The company added that since its inception in 2013, it has increased its dividend by 168%.
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development